Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Research & Development (2021 - 2026)

Alvotech's (ALVO) quarterly Research & Development came in at -$21.9 million in Q2 2026, up 60.05% on a YoY basis from -$13.7 million in Q2 2025, and up 10.82% quarter-over-quarter from -$24.5 million in Q1 2026.

Analysis

Alvotech (ALVO) Research & Development (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Research & Development for 6 consecutive years, with -$21.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development rose 60.05% year-over-year to -$21.9 million; the trailing twelve-month figure through Jun 2026 stood at -$190.9 million (up 35.9% YoY), and the FY2025 full-year result was -$184.2 million, down 7.52% from the prior year.
  • Research & Development climbed to -$21.9 million in Q2 2026 per ALVO's latest filing, from -$24.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $267.5 million in Q2 2022 and bottomed at -$210.8 million in Q1 2023.
  • Historically, Research & Development has averaged -$74.3 million across 5 years, with a median of -$53.2 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Research & Development sank 118.21% in 2023, then soared 76.35% in 2024.
  • Over 5 years, Research & Development stood at -$180.6 million in 2022, then retreated by 16.72% to -$210.8 million in 2023, then gained by 18.74% to -$171.3 million in 2024, then surged by 45.78% to -$92.9 million in 2025, then surged by 76.47% to -$21.9 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered -$21.9 million, -$24.5 million, and -$92.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 970.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 248.30 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 60.90 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 39.02 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 173.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 14.75 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -21.86 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 22.16 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 10.66 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 322,194.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.86 Mn
Mar 31, 2026 -24.51 Mn
Dec 31, 2025 -92.89 Mn
Sep 30, 2025 -51.62 Mn
Jun 30, 2025 -54.72 Mn
Mar 31, 2025 -38.17 Mn
Dec 31, 2024 -171.31 Mn
Sep 30, 2024 -33.57 Mn
Jun 30, 2024 -47.61 Mn
Mar 31, 2024 -49.87 Mn
Dec 31, 2023 -210.83 Mn
Aug 31, 2023 -99.58 Mn
Jun 30, 2023 -48.72 Mn
Mar 20, 2023 -210.83 Mn
Dec 31, 2022 -180.62 Mn
Aug 31, 2022 -86.88 Mn
Jun 30, 2022 267.51 Mn
Mar 20, 2022 -180.62 Mn
Dec 31, 2021 -191.01 Mn
Sep 30, 2021 -56.20 Mn